Efficacy and safety of brentuximab vedotin plus bendamustine in advanced-stage primary cutaneous T-cell lymphomas

MeSH terms

• Acute Kidney Injury / chemically induced
• Acute Kidney Injury / diagnosis
• Adult
• Aged
• Aged, 80 and over
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Bendamustine Hydrochloride / administration & dosage*
• Bendamustine Hydrochloride / adverse effects
• Brentuximab Vedotin / administration & dosage*
• Brentuximab Vedotin / adverse effects
• Dose-Response Relationship, Drug
• Drug Administration Schedule
• Female
• Humans
• Lymphoma, T-Cell, Cutaneous / diagnosis
• Lymphoma, T-Cell, Cutaneous / drug therapy*
• Lymphoma, T-Cell, Cutaneous / pathology
• Male
• Middle Aged
• Neoplasm Staging
• Pneumonia, Pneumocystis / chemically induced
• Pneumonia, Pneumocystis / diagnosis
• Pneumonia, Pneumocystis / immunology
• Severity of Illness Index
• Skin / drug effects
• Skin / pathology
• Skin Neoplasms / diagnosis
• Skin Neoplasms / drug therapy*
• Skin Neoplasms / pathology
• Treatment Outcome